Feb 17 (Reuters) - Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron's approved treatment Eylea in ...

OMAHA, NE - January 21, 2026 - PRESSADVANTAGE - Kugler Vision has released a new educational article titled "SMILE vs ...

By Kamal Choudhury Feb 17 (Reuters) - Ocular Therapeutix's experimental eye drug showed superiority to Regeneron's Eylea in a key late-stage trial, but its modest advantage and higher rates of certain ...

Lehi, Utah - February 09, 2026 - PRESSADVANTAGE - Waite Vision has released new patient education material titled “When ...

Which headset wins? I compare display quality, comfort, M5 power, and price to see if Apple's luxury tech beats Meta's value.

A new national survey released in early 2026 reveals that 50 percent of Maryland drivers who need corrective lenses have not ...

As a robot stared into my eyes, I was perhaps getting a look at the future along with a prescription for eyeglasses. A robot ...

Shiva is a great god in Hindu stories. He is shown with three eyes as the third eye sits in the middle of the brow. It is not ...

Choosing between the Motorola Signature and Oppo Reno 15 isn’t just about specs; it’s about deciding how much flagship power ...

The meat of the Even Realities G2 glasses is what the user sees. It’s the experience of wearing a pair of glasses that shows ...

Ocular Therapeutix has released positive topline results from SOL-1, its phase 3 superiority trial of AXPAXLI for the ...

Remembering Frederick Wiseman, the director of documentaries including Titicut Follies, National Gallery, and Menus-Plaisirs: ...